2008

	PROGRAM 21. ÅRSMØDE DANSK SELSKAB FOR CANCERFORSKNING Onsdag d. 30. april 2008

08.00-08.55	Registrering, opsætning af posters og kaffe
08.55-09.00	Velkomst og Praktiske oplysninger ved Selskabets formand, Kirsten Grønbæk
SESSION I: Chairmen:	Mechanisms and experimental therapy Michael Ploug and Marja Jäättelä
09.00-09:15	Dissection of a stem cell hierarchy in the human breast Agla Jael Rubner Fridriksdottir, Rene Villadsen, Jiyoung Kim, Lone Ronnov-Jessen and Ole William Petersen
09.15-09.30	Targeted suicide gene therapy for small cell lung cancer Camilla Laulund Christensen, Nina Pedersen and Hans Skovgaard Poulsen
09.30-09.45	The role of the Jumonji 2 (JMJD2) Histone Demethylases in Cell Proliferation and Cancer Marianne Terndrup Pedersen and Kristian Helin
09.45-10.00	Lens Epithelium-Derived Growth Factor (LEDGF/p75) is a cancer cell survival factor that controls the expression of decoy TRAIL-receptor 2 (DcR2) Lou Klitgaard Povlsen, Mads Daugaard, Mikkel Rohde, Jakob E. Larsen and Marja Jäättelä
10.00-10.15	Targeting proteases in cancer: Discovery of a novel zymogen targeting inhibitor of urokinase-type plasminogen activator Bøtkjær, KA, Blouse GE, Deryugina EI, Byszuk O, Jensen JM, Mortensen KK, Quigley JP and Andreasen PA.
10.15-10.45	POSTERS & kaffe
SESSION II: Chairmen:	Clinical and preclinical investigations Maxwell Sehested and Per Thor Straten
10.45-11.00	Association of microsatellite instability with thymidylate synthase and dihydropyrimidine dehydrogenase expression in colorectal cancer Søren Astrup Jensen, Ben Vainer, Mogens Kruhøffer and Jens Benn Sørensen.
11.00-11.15	A comparative study of Tissue Inhibitor of Metalloproteinases-1 levels in plasma and tumour tissue from patients with primary breast cancer and in plasma from patients with metastatic breast cancer Anne-Sofie Schrohl, Volkmar Müller, Ib Jarle Christensen, Klaus Pantel, Christoph Thomssen and Nils Brünner.
11.15-11.30	Prognostic impact of C4.4A in non-small cell lung cancer Jacobsen B, Hansen LV, Skov BG, Pappot H and Ploug M.
11.30-11.45	Cancer immunity and autoimmunity; two sides of the same coin (?) Rikke Bæk Sørensen, Mikkel Faurskov, Lone Troelsen, Søren Jacobsen, David Schrama, Jürgen C. Becker, Per Thor Straten and Mads Hald Andersen.
11.45-12.00	CHS-828 identified as novel inhibitor of cellular NAD synthesis Uffe Høgh Olesen, Mette Knak Christensen, Fredrik Björkling, Marja Jäättelä, Peter Buhl Jensen, Maxwell Sehested and Søren Jensby Nielsen.
12.00-12.45	Gårdejer Ingemann Petersen og hustrus Fond, Dansk Selskab for Cancerforsknings hæderspris Introduktion v. Mike Horsman
13.00-13.30	Frokost/kaffe
13.30-14.00	POSTERS
14.00-15.00	The DANISH CANCER SOCIETY LECTURE: Dr. Peter A. Jones, USC Norris Comprehensive Cancer Center, Los Angeles “Epigenetics in Cancer” Introduktion v. Kirsten Grønbæk
15.00-15.30	POSTERS & kaffe
SESSION III: Chairmen:	MicroRNAs in cancer Anders H. Lund and Jan Alsner
15.30-15.35	Introduktion til microRNA Anders H. Lund
15.35-15.50	A new diagnostic platform for prediction of drug response based on a tumor’s microRNA profile Søkilde R, Høiby PE, Friis G, Smith DL, Rickets W, Møller S and Litman T
15.50-16.05	miRNA regulation during oncogene-induced senescence Nanna R Christoffersen, Lisa B Frankel, Mikkel Klausen, Anders Jacobsen, Anders Krogh and Anders H Lund
16.05-16.20	Reintroduction of bladder cancer-downregulated miR-145 results in massive cell death of bladder cancer cell lines Marie S. Ostenfeld, Jesper B. Bramsen, Jørgen Kjems, Torben Ørntoft and Lars Dyrskjøt
16.20-16.35	Inflammation-Induced microRNAs in B-cell lymphoma Irene Munk Pedersen, Kirsten Grønbæk, Christoffer Hother, Elisabeth Ralfkiaer, Croce CM and David M
16.35-17.00	Beer & Snacks
17.00-17.15	Udnævnelse af Æresmedlem i Dansk Selskab for Cancerforskning Introduktion ved Peter A Andreasen.
17.15-17.20	Uddeling af pris for bedste foredrag Bedømmelseskomité: Peter A. Jones og Marie Stockhausen
17.20-17.25	Uddeling af pris for bedste posterpræsentation Bedømmelseskomité: Mike Horsman og Marja Jäättelä
18.30-	Festmiddag